AIIMS INI CET January 2022 Results declared, Details

Published On 2021-11-22 06:00 GMT   |   Update On 2021-11-22 06:00 GMT
Advertisement

Delhi: The All India Institute of Medical Sciences (AIIMS) has announced the results of the Institute of National Importance Combined Entrance Test (INI-CET) January 2022 session.

The results attached below is the roll number wise list of Provisionally Qualified Candidates in Institute of National Importance Combined Entrance Test (INI‐CET) on the basis of performance in Online CBT Examination held on 14‐11‐2021 for admission into postgraduate courses [MD, MS, DM (6 yrs), MCh (6 yrs) and MDS] January 2022 Session at the Institutes of National Importance (INI) for medical education namely, AIIMS‐New Delhi and Nine other AIIMS, JIPMER Puducherry, PGIMER‐Chandigarh, NIMHANS‐Bengaluru & SCTIMST, Trivandrum.

Advertisement

The Final postgraduate seats available for seat allocation based on rank in INI‐CET for January 2022 session has been published on website.

1. This result is published on the basis of information provided by the candidates in the online application for INI‐CET without any scrutiny regarding detailed eligibility, category certificates, sponsorship certificate etc. as applicable.

2. All candidates (including those who have not qualified) have been awarded percentile score based on their performance in INI‐CET held on 14th November 2021. This can be viewed in MyPage on portal (www.aiimsexams.ac.in) after login using Candidate ID and Password.

3. The Qualifying percentile of the qualified candidates have been determined according to the pattern & scheme of Examination mentioned in the Prospectus for Part – A as per following detail:‐

S.No.

CategoryQualifying Percentile
1

For Unreserved (UR), EWS/Sponsored/Deputed/Foreign National/Overseas Citizens of India (OCI) 

50 Percentile

2

OBC, SC, ST, PwBD 

45 Percentile 

3

Bhutanese Nationals (PGI‐Chandigarh only)

45 Percentile 

4. In cases where more than one candidate secures equal MARKS, tie has been resolved by applying the following criteria sequentially:‐

(i) Less negative marks and

(ii) Older by age. 

5. Status after preliminary verification of uploaded certificate (OBC/EWS) will provided in email by 30th November, 2021. Validity of category certificate shall be applicable as published in INI‐CET INFORMATION BROCHURE (Prospectus Part A) – January 2022 Session at page 8 in Note 2. Candidates who have claimed community reservations/relaxation and fail to provide valid certificates and are within the cut‐off percentile for unreserved seats shall be treated as Unreserved. Candidates who have claimed community reservations/relaxation and fail to provide valid certificates and are not within the cut‐off percentile of unreserved seats shall not be considered as qualified even if their roll no appears in this result.

6. This result is provisional subject to fulfillment of the eligibility criteria as laid down in the advertisement, prospectus published and selection is subject to the verification of eligibility, documents in original etc. as applicable to the respective INIS as per prospectus. Any qualified candidate who fails to fulfill eligibility criteria of respective INIs will not be considered for Seat Allocation in that Institute.

7. Candidates, found eligible from the qualified list, on the basis of preliminary scrutiny to be done before start of Seat Allocation, equal to eight times the final total seats as published in each category shall be called for Choice making for Subject & Institute in online Rounds of seat allocation.

8. The detailed procedure for making choice & preference of Institute and Subject for seat allocation on the basis of INI‐CET Rank will be notified on the website www.aiimsexams.ac.in

9. All communication shall be made through website/email/SMS on www.aiimsexams.ac.in/ registered email address/ registered mobile number of the candidates. AIIMS is not responsible for any loss on account of delay in access of website/email/SMS or failure of non delivery of email/SMS. All candidate should remain alert and visit website for more details.



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News